key: cord-1048988-qz613rzn
authors: Ghosh, Ritwik; Dubey, Souvik; Mandal, Arpan; Ray, Biman Kanti; Benito-León, Julian
title: Complex movement disorders in SARS-CoV-2 infection induced acute disseminated encephalomyelitis
date: 2021-06-30
journal: J Neuroimmunol
DOI: 10.1016/j.jneuroim.2021.577655
sha: 14d8e7bf4a280f41165234bae4ed5efb1c05facb
doc_id: 1048988
cord_uid: qz613rzn

Movement disorders are extremely rare in acute disseminated encephalomyelitis (ADEM) and in the novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection. We herein report a 34-years-old previously healthy woman who presented with a febrile illness and a constellation of movement disorders (predominantly myoclonus) followed by encephalopathy. After exclusion of common infectious, autoimmune and paraneoplastic etiologies, she was diagnosed to have COVID-19 induced ADEM, which responded to intravenous methylprednisolone and intravenous immunoglobulin. Our case adds to the tally of cases of post-SARS-CoV-2 infection related movement disorders and to the exceedingly rare list of cases in which movement disorders preceded ADEM.

Acute disseminated encephalomyelitis (ADEM) is a serious autoimmune demyelinating disorder of the central nervous system (CNS) that often occurs post infectiously (Pohl et al., 2016) . Multifocal neurological deficits, headache and encephalopathy usually constitute the clinical spectrum of ADEM (Pohl et al., 2016) . Magnetic resonance imaging (MRI) typically demonstrates acute, ill-defined, multifocal and reversible white matter lesions with frequent involvement of basal ganglia, thalamus, and brainstem and rarely of the spinal cord. 1 Early immunotherapy is the cornerstone of treatment (Pohl et al., 2016) .

Movement disorders are extremely rare in acute disseminated encephalomyelitis (ADEM) (Ha and Sue, 2010; Kabakus et al., 2006; Mehanna and Jankovic, 2013; Park et al., 2016) , as well as in the novel severe acute respiratory syndrome coronavirus (SARS-CoV-2) infection and have not been reported in the few published cases of the coronavirus infectious disease of 2019 (COVID-19) induced ADEM (AM et al., 2020; Novi et al., 2020; Parsons et al., 2020) .

We herein report the case of a previously healthy woman who presented with a constellation of movement disorders (predominantly myoclonus) followed by encephalopathy. After exclusion of common infectious, autoimmune and paraneoplastic causes, she was diagnosed as a case of COVID-19 induced ADEM, which responded to immunomodulatory therapies.

J o u r n a l P r e -p r o o f 

ADEM is an autoimmune monophasic multifocal demyelinating disorder of central nervous system, which is frequently associated with preceding viral infections (Pohl et al., 2016) . In recent times, though rarely, SARS-CoV-2 infection has been linked to development of ADEM both in adult and pediatric patients (AM et al., 2020; Novi et al., 2020; Parsons et al., 2020) . Pathogenetic mechanisms for the development of ADEM following SARS-CoV-2 infection may be either mediated by direct neurotropism or by aberrant immune mediated injury, the latter being the most likely (AM et al., 2020; Ghosh et al., 2020; Novi et al., 2020; Parsons et al., 2020; Roy et al., 2020) .

Movement disorders, as a presenting manifestation of ADEM, are extremely rare and more so in adults (Ha and Sue, 2010; Kabakus et al., 2006; Mehanna and Jankovic, 2013; Park et al., 2016) . Whether a case of ADEM will develop movement disorders or not, will certainly depend upon involvement of areas of brain that control movements (basal ganglia and its connections). Specifically, ataxia, myoclonus, dystonia, chorea and tremor have been reported in ADEM (Ha and Sue, 2010; Kabakus et al., 2006; Mehanna and Jankovic, 2013; Park et al., 2016) . On the other hand, movement disorders are sparsely reported in SARS-CoV-2 infection. (Ghosh et al., 2021; Rábano-Suárez et al., 2020; Roy et al., 2020) The most commonly movement disorders reported in COVID-19 have been different types of myoclonus, followed by opsoclonus, ataxia, hypokinetic-rigid syndrome and tremor.(Roy et al., Figure 1 

Acute disseminated encephalomyelitis in a COVID-19 pediatric patient

A case of area postrema variant of neuromyelitis optica spectrum disorder following SARS-CoV-2 infection

Choreo-ballistic movements heralding COVID-19 induced diabetic ketoacidosis

ADEM presenting as a movement disorder

Segmental myoclonus as the presenting symptom of an acute disseminated encephalomyelitis: a case report

Movement disorders in multiple sclerosis and other demyelinating diseases

Acute disseminated encephalomyelitis after SARS-CoV-2 infection

Acute disseminated encephalomyelitis with tremor as the initial symptom

COVID-19-associated acute disseminated encephalomyelitis (ADEM

Acute disseminated encephalomyelitis: Updates on an inflammatory CNS syndrome

Generalized myoclonus in COVID-19

Neurological and Neuropsychiatric Impacts of COVID-19 Pandemic